Sale!

FBN1 Gene MASS Syndrome NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The FBN1 Gene MASS Syndrome NGS Genetic DNA Test is a comprehensive genetic analysis that detects mutations in the FBN1 gene associated with MASS syndrome, a connective tissue disorder. This advanced test utilizes Next Generation Sequencing technology to identify specific genetic variations that can affect cardiovascular health, skeletal development, and connective tissue integrity. The test is particularly important for individuals with family history of connective tissue disorders, unexplained skeletal abnormalities, or cardiovascular concerns. Results provide crucial information for early intervention, personalized treatment planning, and genetic counseling. The test is available for $500 USD (regularly $700 USD) and provides results within 3-4 weeks using blood, extracted DNA, or blood spot samples. Genetic counseling is recommended before testing to ensure proper understanding of results and implications.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

FBN1 Gene MASS Syndrome NGS Genetic DNA Test

Comprehensive Genetic Testing for Connective Tissue Health

The FBN1 Gene MASS Syndrome NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for connective tissue disorders. This advanced test specifically targets mutations in the FBN1 gene, which plays a critical role in the formation and maintenance of connective tissues throughout the body. MASS syndrome, while sharing some features with Marfan syndrome, presents unique clinical characteristics that require specialized genetic analysis for accurate diagnosis and management.

What Does This Test Measure and Detect?

Our FBN1 Gene MASS Syndrome test utilizes cutting-edge Next Generation Sequencing (NGS) technology to comprehensively analyze the entire FBN1 gene. This sophisticated approach enables us to detect:

  • Point mutations and single nucleotide variants in the FBN1 gene
  • Small insertions and deletions that may disrupt protein function
  • Missense mutations affecting fibrillin-1 protein structure
  • Nonsense mutations leading to premature stop codons
  • Splice site variants that impact gene expression

The test specifically identifies genetic variations associated with MASS syndrome phenotype, which includes Mitral valve prolapse, Aortic root dilation, Skeletal changes, and Skin findings – the characteristic features that define this connective tissue disorder.

Who Should Consider This Genetic Test?

This comprehensive genetic analysis is recommended for individuals presenting with:

  • Family history of connective tissue disorders or MASS syndrome
  • Unexplained skeletal abnormalities or joint hypermobility
  • Mitral valve prolapse detected during cardiac evaluation
  • Mild aortic root dilation without other Marfan syndrome features
  • Characteristic skin findings including striae or soft, velvety skin texture
  • Tall stature with disproportionate limb length
  • Myopia or other vision concerns without clear etiology
  • Children with developmental concerns related to connective tissue function

Clinical Benefits of FBN1 Genetic Testing

Early detection through FBN1 genetic testing provides numerous clinical advantages:

  • Accurate Diagnosis: Differentiate MASS syndrome from other connective tissue disorders with overlapping symptoms
  • Personalized Management: Develop targeted monitoring and treatment plans based on specific genetic findings
  • Family Planning Guidance: Understand inheritance patterns and recurrence risks for future generations
  • Preventive Care: Implement early interventions to manage potential cardiovascular and skeletal complications
  • Psychological Relief: Provide clarity and reduce diagnostic uncertainty for patients and families

Understanding Your Test Results

Our genetic counseling team provides comprehensive interpretation of your FBN1 test results:

  • Positive Result: Indicates the presence of a pathogenic FBN1 mutation associated with MASS syndrome. This result enables targeted medical management and family screening.
  • Negative Result: Suggests that no disease-causing mutations were detected in the FBN1 gene, though clinical follow-up may still be recommended based on symptoms.
  • Variant of Uncertain Significance (VUS): Identifies genetic changes with unclear clinical implications, requiring ongoing monitoring and potential family studies.

All results are accompanied by detailed explanations and recommendations from our board-certified genetic counselors to ensure complete understanding and appropriate next steps.

Test Pricing and Availability

Test Component Price (USD)
FBN1 Gene MASS Syndrome NGS Genetic DNA Test – Discount Price $500
FBN1 Gene MASS Syndrome NGS Genetic DNA Test – Regular Price $700

Nationwide Testing Availability

We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.

Take Control of Your Genetic Health Today

Don’t let uncertainty about connective tissue health concerns affect your quality of life. Our FBN1 Gene MASS Syndrome NGS Genetic DNA Test provides the clarity and information needed for informed healthcare decisions. With results available in just 3-4 weeks and multiple sample collection options (blood, extracted DNA, or blood spot cards), getting tested has never been more convenient.

Call us now at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our genetic specialists are available to answer your questions and guide you through the testing process with compassion and expertise.

Remember: Early detection through genetic testing can lead to better management outcomes and improved quality of life for individuals with connective tissue disorders. Take the first step toward understanding your genetic health today.